Vol 4 (December 30, 2022): Frontiers of Oral and Maxillofacial Medicine

Case Report 
Oral rehabilitation through the application of a xenogenous bone graft prior to placement of a dental implant: a case report with 9 years of follow-up
Paulo Martins Ferreira, William Phillip Pereira da Silva, Felipe Ramalho Ferreira, Gabriel Ramalho Ferreira, Paulo Fukasji Yamaguti, Leonardo Alan Delanora, Alberto Consolaro, Leonardo Perez Faverani
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
40  
Review Article 
Osseointegration—the biological reality of successful dental implant therapy: a narrative review
Lyndon F. Cooper, Sajjad Shirazi
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
39  
Review Article 
Peri-implant disease: early diagnosis and non-surgical treatment—a narrative literature review
TaeHyun Kwon, Howard H. Yen, Liran Levin
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
38  
Review Article 
Treatment of advanced peri-implantitis with regenerative therapy: a review of the rationale, technique, and outcomes
Stuart J. Froum
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
37  
Review Article 
Immediate versus conventional loading (IL vs. CL) influence on implant marginal bone loss (MBL): an overview
Rebeca Serrano Zamora, Óscar Iglesias Velázquez, Baoluo Xing Gao, Carmen Martín Carreras-Presas, Juan López-Quiles
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
36  
Original Article 
Impact of treatment modalities on oral cancer patients’ health-related quality of life over a time trajectory
Jennifer Geraldine Doss, William Murray Thomson, Bernadette K. Drummond, Wan Maria Nabillah Ghani
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
35  
Original Article 
Association between implant surface roughness, smoking habits and implant site location on the occurrence of peri-implantitis: a pooled retrospective cohort study
Luca Ferrantino, Massimo Simion, Anna Zanetti, Antonella Zambon
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
34  
Original Article 
MiR-29c-3p and MiR-223-3p regulate the proliferation and drug resistance of oral squamous cell carcinoma by targeting ANGPTL4
Lijuan Bian, Xi Rui, Zixian Huang, Yan Wang, Zhiquan Huang
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
33  
Consensus 
Chinese expert consensus on the use of oral propranolol for treatment of infantile hemangiomas (version 2022)
Jia-Wei Zheng, Xu-Kai Wang, Zhong-Ping Qin, Xin-Dong Fan, Kai Li, Yao-Wu Yang, Ran Huo, Shao-Hua Liu, Ji-Hong Zhao, Xiao-Yong Wang, De-Kai Zhou, Xue-Jian Liu
Frontiers of Oral and Maxillofacial Medicine  
2022;
4:
32